Phantom Neuro Joins Amputee Coalition's Partnership Program
Summary
Phantom Neuro announced it has joined the Partnership Program of the Amputee Coalition, the largest US nonprofit supporting the more than 5.6 million Americans living with limb loss or limb difference. The move formalizes a relationship between the neural-interface company, whose Phantom X system is designed to give prosthetic and robotic devices natural, muscle-signal-driven control, and the patient community it is ultimately building for. Phantom Neuro is already in an FDA-approved first-in-human study of Phantom X, following Breakthrough Device and TAP designations from the agency.
Why it matters
Formal ties to patient advocacy groups give device companies a direct channel to the people who will actually use their technology, shaping trial design and real-world adoption in ways that pure engineering partnerships don't.
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items β updated daily.
Start free trial